|
⚲
|
| Keyboard |
| Davern Capital Partners LP
✚
|
|
|---|---|
| CRD # | 323018 |
| SEC # | 801-134155 |
| CIK # | 0002003147 |
| AUM | 715.1 M (2026-03-27) |
| Employees | 4 (75% Investors, 0% Brokers) |
| Fees | |
| Minimum | |
| Phone | 646-485-6541 |
| Address | 300 Park Avenue New York, NY 10022 |
| Source | [IAPD] [EDGAR] [Website] [LinkedIn] |
| Total AUM ($M) |
|---|
| CIK | Period |
|---|---|
| 0002003147 |
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Pfizer Inc | 44.8 | ||
| Regeneron Pharmaceuticals Inc | 34.6 | ||
| Insmed Inc | 29.9 | ||
| ISIS Pharmaceuticals Inc | 29.1 | ||
| Natera Inc | 28.8 | ||
| Biontech SE | 27.1 | ||
| Argenx SE | 25.6 | ||
| Lilly Eli & Co | 25.1 | ||
| Royalty Pharma PLC | 24.9 | ||
| Roivant Sciences Ltd | 24.2 | ||
| Legend Biotech Corp | 23.8 | ||
| Mineralys Therapeutics Inc | 12.1 | ||
| Abivax Sa | 8.7 | ||
| Procept Biorobotics Corp | 6.5 | ||
| Structure Therapeutics Inc | 6.1 | ||
| Signal Genetics Inc | 5.9 | ||
| Prev | Page 1 | Next | |||
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| HF | Davern Capital Partners Master Fund LP | [2023-01-27] | 30.7 M | 55.1 M |
| Filed 2026-01-20 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 2 | 55.1 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 1 | 660.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 3 | 715.1 |
| By Discretionary | ||
| Discretionary | 3 | 715.1 |
| Non-Discretionary | 0 | 0.0 |
| Total | 3 | 715.1 |
| By Non-United States Persons | ||
| Non-United States Persons | 715.1 | |
| United States Persons | 0.0 | |
| Total | 3 | 715.1 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Susanna Schankler | Executive Officer | 1 | 1 | |
| Davern Capital Partners LP | Executive Officer | 1 | 1 | |
| Elie Kobrin | Executive Officer | 1 | 1 | |
| Davern Capital Partners GP LLC | Promoter | 1 | 1 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0002003147] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional |
| Fund Types | Hedge Fund |
| LEI | 549300QRAORJ2IS9FU25 |
| Comparable Firms | State | AUM |
|---|---|---|
|
Philadelphia Financial Management of San Francisco LLC
✚
|
CA | 730.0 M |
|
The Cypress Funds LLC
✚
|
CA | 723.2 M |
|
Medina Value Partners LLC
✚
|
CA | 717.2 M |
|
LYGH Capital PTE Ltd
✚
|
716.6 M | |
|
RV Capital AG
✚
|
713.3 M | |
|
TB Alternative Assets Ltd
✚
|
708.2 M | |
|
Corrigo Investment Partners LLC
✚
|
TX | 707.2 M |
|
Marchant MC Limited
✚
|
705.1 M | |
|
Southeastern Asset Management International Singapore PTE Ltd
✚
|
702.7 M | |
|
Entrypoint Capital LLC
✚
|
NY | 700.3 M |